PARIS--(BUSINESS WIRE)-- Sanofi, a global and diversified healthcare leader, held its annual Investor Relations Thematic Seminar, focused this year on the group's strategy and outlook. CEO Chris Viehbacher comments on the key messages to investors.
Click to watch the video:
http://www.eurobusinessmedia.com/Sanofi-video-Q-A-CEO-Chris-Viehbacher-comments-on-key-messages-from-the-Investor-Relations-Seminar?utm_source=ceo-direct&utm_medium=bw
Topics covered in the interview include:
- Industry resilience
- Company transformation
- Growth platforms
- Genzyme
- Innovative products
- Guidance for 2012-2015
- Shareholder return
About Sanofi:
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Company website: www.sanofi.com
CONTACT:
SANOFI
Investor Relations:
Sébastien Martel
[email protected]
+33 1 53 77 45 45
or
Media Relations:
[email protected]
+33 (0)1 53 77 45 02
KEYWORDS: United States Europe North America France New York
INDUSTRY KEYWORDS: Health Communications Public Relations/Investor Relations Diabetes Medical Supplies
MEDIA:
| Logo |